Expert Opinion

Focus articles on the therapeutic options for acute and advanced heart failure are available here, containing new data, new studies, new opinions and new trends from Professor Gerhard Pölzl, Chief of the Heart Failure and Heart Transplant Program at the Medical University Innsbruck. His research is focused on clinical studies in advanced and chronic heart failure and on translational studies in cardiomyopathies.

He was Principal Investigator of the LevoRep clinical trial that tested the efficacy and safety of pulsed infusions of levosimendan in outpatients with advanced heart failure. He is now PI of the clinical trial LEODOR, on repetitive use of levosimendan in advanced heart failure.

Login/ Register Maximise Minimise